Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Government of Canada was posted on January 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Micronucleus Scoring in Human Blood Samples Collected from Wildland Firefighters

Closed
1000267939International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This contract involves the secure shipment and specialized analysis of human peripheral blood samples collected from wildland firefighters, focusing on scoring micronucleus incidence as early biomarkers of cancer risk. Health Canada requires a qualified contractor to handle the irreplaceable biological samples and perform flow cytometric analysis to ensure accurate data collection essential for the research project's successful completion. The project is part of the National Framework on Cancers Linked to Firefighting and aims to identify genotoxic effects that may contribute to cancer risk in this high-risk occupational group. Issued by the Department of Health under the Government of Canada, the solicitation was posted on January 7, 2026, with a response deadline of January 22, 2026. The contract emphasizes the importance of secure logistics and the application of highly specialized laboratory techniques to maintain sample integrity and data reliability. The contracting authority for this opportunity is Teresa Mckenny, who can be contacted for further information. The place of performance is within Canada, and the procurement is managed through the federal government's official tender platform.

General Info

Secure shipment and analysis of firefighter blood samples to detect cancer risk biomarkers in Canada.

Agency

Government of Canada → Department of HealthView Agency

NAICS

541380 - Testing Laboratories and ServicesView NAICS

Place of Performance

*Canada, CAN

Set-Aside

NONE

Documents

(2)

Advance Contract Award Notice 1000267939 - Micronucleus Scoring in Wildland Firefighters

PDF4 pagesacan

Préavis d’Adjudication de Contrat 1000267939 - Évaluation de la Fréquence des Micronoyaux

PDF4 pagespresolicitation

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Health
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Department of Health
View Agency Profile
Office AddressN/A
Contacts
Teresa MckennyPoint of Contact

Full Description

Show more
Successful achievement of key milestones specified in the research project entitled Genotoxic Effects as Early Biomarkers of Cancer Risk in Wildland Firefighters is contingent upon the scoring of micronucleus incidence in human peripheral blood samples. Given the irreplaceable nature of the biological samples, and the highly specialized nature of the analysis, Health Canada requires a qualified contractor to ensure the secure shipment of blood samples and the execution of the flow cytometric analysis (i.e., for scoring of micronucleus incidence in each sample). The project is funded under the National Framework on Cancers Linked to Firefighting.

More opportunities from Government of Canada → Department of Health

Same awarding agency

NAICS: 541715
International
Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.
Solicitation # 1000273405
Health Canada is seeking proposals under solicitation 1000273405 to conduct in vitro pharmacological testing of novel psychoactive substances to support regulatory science and risk assessments regarding the illegal drug supply. The procurement is divided into three separate streams: Stream 1 focuses on emerging opioids at the Mu Opioid Receptor, Stream 2 addresses novel synthetic cannabinoids targeting CB1 and CB2 receptors, and Stream 3 evaluates stimulant compounds, specifically dopamine and VMAT2 uptake. Bidders may submit proposals for a single stream, two streams, or all three, with the possibility of up to three contracts being awarded. The selected contractors will be responsible for acquiring reference standards and control samples, obtaining necessary licenses for controlled substances, and performing rigorous laboratory experiments including assay validation and pharmacodynamic testing. Key deliverables include the measurement of metrics such as Ki, Emax, and EC50, followed by statistical analysis and the submission of draft and final reports. Timelines for completion vary by stream, with some activities extending up to 17.5 months from the date of the contract award. Technical and financial offers must be submitted separately for each stream by the deadline of September 18, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

10 days ago

DEADLINE

in 8 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS